Skip to content
S5312Senate2011-2012 Session

Relates to hypodermic syringes

Sponsor Thomas K. DuaneSD-29Affects Health
Status
In Senate Committee
Health
Impact
Pending
Passage
Pending

Bill progress

Step 2 of 7

In committee · Health

What's happening

Writing a plain-English summary… Track this bill to get it by email.

Why it matters

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Who cares

Headline styles

Sponsors

Primary sponsor
Thomas K. Duane

Senator · Senate District 29

No co-sponsors yet.

History

  1. Referred to health
  2. Reported and committed to finance
  3. Referred to health

Full text

The text isn't available here yet. Check nysenate.gov.

Sponsor's memo

BILL NUMBER:S5312

Title of bill

An act to amend the public health law, in relation to hypodermic syringes

Purpose

This bill would further the public health objectives of the Expanded Syringe Access Program (ESAP) by repealing provisions that limit the quantity of syringes that may be sold or furnished during one transaction to ten or fewer and prohibit pharmacies from advertising the availability of these syringes to the public.

Read the full memo (738 words)

Summary of provisions

Section 1 of the bill would amend Public Health Law (PHL) § 3381(1) to permit pharmacies, health care facilities licensed under PHL Article 28 and health care practitioners that are authorized to sell or otherwise furnish hypodermic syringes to persons without a prescription to provide more than ten syringes in a single transaction.

Section 1 of the bill would also repeal PHL § 3381(5)(d)(i), which currently prohibits pharmacies from advertising the retail availability of syringes without a prescription.

Section 2 of the bill provides that the bill would take effect immediately.

Existing law

PHL § 3381 authorizes pharmacies, health care facilities licensed under PHL Article 28, and health care practitioners otherwise authorized to prescribe syringes within their scope of practice to sell or provide syringes without a prescription to persons who are 18 years of age or older and in quantities of 10 or less per transaction. A "safety insert" must be provided each time a syringe is sold or dispensed, and pharmacies that sell syringes may not advertise them to the public.

Legislative history

This is a new bill.

Statement in support

More than 3,000 pharmacies, health care facilities and practitioners have registered with the Department of Health (DOH) to sell or furnish syringes to those age 18 and over without a prescription under the ESAP. This program makes syringes available without a prescription and promotes the safe disposal of used syringes. Research has shown this program effectively reduces transmission of blood-borne pathogens as a result of needle sharing and reuse and may increase safe disposal of used syringes. ESAP providers sell two to three million

non-prescription syringes a year and the need for unrestricted access to syringes remains high. Only two states, Delaware and New Jersey, do not allow the sale of syringes without a prescription. In a 2003 report, the New York Academy of Medicine (NYAM) stated that

ESAP "has great potential to prevent transmission of blood-borne diseases without any detrimental effect on syringe disposal, drug use or crime." NYAM's recommendation included: (1) enacting legislation to allow the program to continue permanently (which occurred as part of the 2009-10 enacted budget); (2) lifting the restriction on pharmacy advertising; (3) continuing education and outreach; (4) continuing safe syringe disposal education; and (5) expanding disposal options. At the time of the program's extension through 2007, NYAM again noted the importance of syringe access, indicating that expanded syringe access "is critically important to stemming the spread of infectious disease." Numerous studies published in peer-reviewed journals have attested to the value of ESAP in reducing syringe sharing and re-use and preventing disease transmission.

This bill would eliminate two restrictions on the sale of syringes to further the objectives of ESAP. First, the bill would remove the restriction on the number of syringes that may be sold or furnished, leaving the matter to the discretion of the individual ESAP provider. The current limit of 10 syringes per transaction was first implemented when ESAP was a demonstration project. Removing the limitation would better serve individuals who use this program by ensuring that they have enough clean syringes to prevent reusing or sharing syringes. For individuals in rural regions of the State, removing this restriction will facilitate access, particularly when it may be difficult or time-consuming to get to a pharmacy to purchase or dispose of used syringes.

Second, the bill would permit pharmacies to advertise the availability of syringes to the public. Of the 3,300 pharmacies, health care facilities and practitioners that have registered with DOH as part of

ESAP, more than 97 percent are pharmacies. The public health function that they serve is compromised if potential customers are unaware of which pharmacies are registered ESAP providers. Appropriate pharmacy advertising can supplement the efforts of DOH to promote ESAP and provide consumers with access to information that they need to make informed choices.

Budget implications

This bill is not anticipated to have a fiscal impact to the State or any locality.

Effective date

This bill would take effect immediately.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.